Moreover, the data obtained from the disease-free interval (DFI) analysis suggested that RBMX is a protective factor in BRCA, brain lower grade glioma (LGG), READ, stomach adenocarcinoma (STAD), and THCA. This evidence concerns the gene RBMX and reading.